These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17502778)

  • 21. Comparing the methods used to compare antidepressants.
    Thase ME
    Psychopharmacol Bull; 2002; 36 Suppl 1():Suppl 1-17; quiz Suppl 18-9. PubMed ID: 12395691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized clinical trials: the meeting place of medical practice and clinical research.
    Hughes EG
    Semin Reprod Med; 2003 Feb; 21(1):55-64. PubMed ID: 12806560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of randomized clinical trials in tinnitus.
    Dobie RA
    Laryngoscope; 1999 Aug; 109(8):1202-11. PubMed ID: 10443820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methodology to measure onset of action.
    Thase ME
    J Clin Psychiatry; 2001; 62 Suppl 15():18-21. PubMed ID: 11444762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.
    Hennings JM; Owashi T; Binder EB; Horstmann S; Menke A; Kloiber S; Dose T; Wollweber B; Spieler D; Messer T; Lutz R; Künzel H; Bierner T; Pollmächer T; Pfister H; Nickel T; Sonntag A; Uhr M; Ising M; Holsboer F; Lucae S
    J Psychiatr Res; 2009 Jan; 43(3):215-29. PubMed ID: 18586274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective exclusion of treatment arms in multi-arm randomized clinical trials.
    Law MG; Emery S
    Stat Med; 2003 Jan; 22(1):19-30. PubMed ID: 12486749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trials of potential antidepressants: to what extent are the elderly represented: a review.
    Giron MS; Fastbom J; Winblad B
    Int J Geriatr Psychiatry; 2005 Mar; 20(3):201-17. PubMed ID: 15717338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Have Treatment Studies of Depression Become Even Less Generalizable? Applying the Inclusion and Exclusion Criteria in Placebo-Controlled Antidepressant Efficacy Trials Published over 20 Years to a Clinical Sample.
    Zimmerman M; Balling C; Chelminski I; Dalrymple K
    Psychother Psychosom; 2019; 88(3):165-170. PubMed ID: 31096246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational antidepressant selection: applying evidence-based medicine to complex real-world patients.
    Zetin M; Hoepner CT; Bjornson L
    Psychopharmacol Bull; 2006; 39(1):38-104. PubMed ID: 17065974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are samples in randomized controlled trials of psychotherapy representative of community outpatients? A new methodology and initial findings.
    Stirman SW; DeRubeis RJ; Crits-Christoph P; Brody PE
    J Consult Clin Psychol; 2003 Dec; 71(6):963-72. PubMed ID: 14622071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs.
    Merlo-Pich E; Alexander RC; Fava M; Gomeni R
    Clin Pharmacol Ther; 2010 Nov; 88(5):634-42. PubMed ID: 20861834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer, comorbidity, and participation in randomized controlled trials of therapy.
    Chao HH; Mayer T; Concato J; Rose MG; Uchio E; Kelly WK
    J Investig Med; 2010 Mar; 58(3):566-8. PubMed ID: 20072029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inclusion/exclusion criteria in late life depression antidepressant efficacy trials.
    Zimmerman M; Multach MD; Clark HL; Walsh E; Rosenstein LK; Gazarian D
    Int J Geriatr Psychiatry; 2017 Sep; 32(9):1009-1016. PubMed ID: 27546477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Redefining the randomized controlled trial in the context of acupuncture research.
    Walji R; Boon H
    Complement Ther Clin Pract; 2006 May; 12(2):91-6. PubMed ID: 16648085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labeling.
    Zimmerman M; Clark HL; Multach MD; Walsh E; Rosenstein LK; Gazarian D
    J Affect Disord; 2016 Jan; 190():357-361. PubMed ID: 26546771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A reevaluation of the exclusion criteria used in antidepressant efficacy trials.
    Posternak MA; Zimmerman M; Keitner GI; Miller IW
    Am J Psychiatry; 2002 Feb; 159(2):191-200. PubMed ID: 11823258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying patients at risk of complete nonresponse in the outpatient treatment of depression.
    Van HL; Dekker J; Peen J; van Aalst G; Schoevers RA
    Psychother Psychosom; 2008; 77(6):358-64. PubMed ID: 18701832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis.
    Heo M; Murphy CF; Meyers BS
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):899-905. PubMed ID: 17911366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes for antidepressant trials in late-life depression.
    Meyers BS; Bruce ML
    Psychopharmacol Bull; 1997; 33(4):701-5. PubMed ID: 9493482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.